Clinical Trial Update: Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia [NA]

View source ↗

Summary

A clinical trial evaluating Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in individuals with treatment-resistant schizophrenia; cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I)

Snippet

Sponsor: Jimmi Nielsen | Conditions: Treatment-refractory Schizophrenia, Treatment-resistant Schizophrenia | NA | Status: RECRUITING